This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, X. Articles by White, K. E. Search for Related Content PubMed PubMed Citation Articles by Yu, X. Articles by White, K. E.

Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23

Department of Medical & Molecular Genetics (X.Y., S.I.D., H.J.G., K.E.W.), Indiana University School of Medicine, Indianapolis, Indiana 46202; Department of Pharmacology (O.A.I., R.G., M.M.), New York University School of Medicine, New York, New York 10016; Department of Chemistry & Chemical Biology (F.Z., R.J.L.), Rensselaer Polytechnic Institute, Troy, New York 12180; and Department of Molecular Biology and Pharmacology (D.M.O.), Washington University Medical School, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: Kenneth E. White, Ph.D., 975 West Walnut Street, IB130, Indiana University School of Medicine, Indianapolis, Indiana 46202. E-mail: kenewhit{at}iupui.edu.

Fibroblast growth factor (FGF)-23 has emerged as an endocrine regulator of phosphate and of vitamin D metabolism. It is produced in bone and, unlike other FGFs, circulates in the bloodstream to ultimately regulate phosphate handling and vitamin D production in the kidney. Presently, it is unknown which of the seven principal FGF receptors (FGFRs) transmits FGF23 biological activity. Furthermore, the molecular basis for the endocrine mode of FGF23 action is unclear. Herein, we performed surface plasmon resonance and mitogenesis experiments to comprehensively characterize receptor binding specificity. Our data demonstrate that FGF23 binds and activates the c splice isoforms of FGFR1–3, as well as FGFR4, but not the b splice isoforms of FGFR1–3. Interestingly, highly sulfated and longer glycosaminoglycan (GAG) species were capable of promoting FGF23 mitogenic activity. We also show that FGF23 induces tyrosine phosphorylation and inhibits sodium-phosphate cotransporter Npt2a mRNA expression using opossum kidney cells, a model kidney proximal tubule cell line. Removal of cell surface GAGs abolishes the effects of FGF23, and exogenous highly sulfated GAG is capable of restoring FGF23 activity, suggesting that proximal tubule cells naturally express GAGs that are permissive for FGF23 action. We propose that FGF23 signals through multiple FGFRs and that the unique endocrine actions of FGF23 involve escape from FGF23-producing cells and circulation to the kidney, where highly sulfated GAGs most likely act as cofactors for FGF23 activity. Our biochemical findings provide important insights into the molecular mechanisms by which dysregulated FGF23 signaling leads to disorders of hyper- and hypophosphatemia.

This article has been cited by other articles:

				T. Nakatani, M. Ohnishi, and M. S. Razzaque Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model FASEB J, November 1, 2009; 23(11): 3702 - 3711. [Abstract] [Full Text] [PDF]

				P. Liu, X. Bai, H. Wang, A. Karaplis, D. Goltzman, and D. Miao Hypophosphatemia-mediated hypotension in transgenic mice overexpressing human FGF-23 Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1514 - H1520. [Abstract] [Full Text] [PDF]

				J. Gattineni, C. Bates, K. Twombley, V. Dwarakanath, M. L. Robinson, R. Goetz, M. Mohammadi, and M. Baum FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1 Am J Physiol Renal Physiol, August 1, 2009; 297(2): F282 - F291. [Abstract] [Full Text] [PDF]

				M. Kuro-o Klotho in chronic kidney disease--What's new? Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1705 - 1708. [Full Text] [PDF]

				O. M. Gutierrez, J. L. Januzzi, T. Isakova, K. Laliberte, K. Smith, G. Collerone, A. Sarwar, U. Hoffmann, E. Coglianese, R. Christenson, et al. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease Circulation, May 19, 2009; 119(19): 2545 - 2552. [Abstract] [Full Text] [PDF]

				M. S. Razzaque FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol, March 1, 2009; 296(3): F470 - F476. [Abstract] [Full Text] [PDF]

				T. Nakatani, B. Sarraj, M. Ohnishi, M. J. Densmore, T. Taguchi, R. Goetz, M. Mohammadi, B. Lanske, and M. S. Razzaque In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis FASEB J, February 1, 2009; 23(2): 433 - 441. [Abstract] [Full Text] [PDF]

				S. Liu, L. Vierthaler, W. Tang, J. Zhou, and L. D. Quarles FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23 J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2342 - 2350. [Abstract] [Full Text] [PDF]

				D. Medici, M. S. Razzaque, S. DeLuca, T. L. Rector, B. Hou, K. Kang, R. Goetz, M. Mohammadi, M. Kuro-o, B. R. Olsen, et al. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis J. Cell Biol., August 11, 2008; 182(3): 459 - 465. [Abstract] [Full Text] [PDF]

				O. M. Gutierrez, M. Mannstadt, T. Isakova, J. A. Rauh-Hain, H. Tamez, A. Shah, K. Smith, H. Lee, R. Thadhani, H. Juppner, et al. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis N. Engl. J. Med., August 7, 2008; 359(6): 584 - 592. [Abstract] [Full Text] [PDF]

				S. Liu, J. Zhou, W. Tang, R. Menard, J. Q. Feng, and L. D. Quarles Pathogenic role of Fgf23 in Dmp1-null mice Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E254 - E261. [Abstract] [Full Text] [PDF]

				R. Marsell, T. Krajisnik, H. Goransson, C. Ohlsson, O. Ljunggren, T. E. Larsson, and K. B. Jonsson Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23 Nephrol. Dial. Transplant., March 1, 2008; 23(3): 827 - 833. [Abstract] [Full Text] [PDF]

				F. Perwad, M. Y. H. Zhang, H. S. Tenenhouse, and A. A. Portale Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1{alpha}-hydroxylase expression in vitro Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1577 - F1583. [Abstract] [Full Text] [PDF]

				M. S Razzaque and B. Lanske The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis J. Endocrinol., July 1, 2007; 194(1): 1 - 10. [Abstract] [Full Text] [PDF]

				T. B. Drueke and D. Prie Klotho spins the thread of life--what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)? Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1524 - 1526. [Full Text] [PDF]

				S. Liu and L. D. Quarles How Fibroblast Growth Factor 23 Works J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1637 - 1647. [Abstract] [Full Text] [PDF]

				V. P. Eswarakumar and J. Schlessinger Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3 PNAS, March 6, 2007; 104(10): 3937 - 3942. [Abstract] [Full Text] [PDF]

				H. Segawa, S. Yamanaka, Y. Ohno, A. Onitsuka, K. Shiozawa, F. Aranami, J. Furutani, Y. Tomoe, M. Ito, M. Kuwahata, et al. Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice Am J Physiol Renal Physiol, February 1, 2007; 292(2): F769 - F779. [Abstract] [Full Text] [PDF]

				S. Liu, J. Zhou, W. Tang, X. Jiang, D. W. Rowe, and L. D. Quarles Pathogenic role of Fgf23 in Hyp mice Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E38 - E49. [Abstract] [Full Text] [PDF]

				X. Zhang, O. A. Ibrahimi, S. K. Olsen, H. Umemori, M. Mohammadi, and D. M. Ornitz Receptor Specificity of the Fibroblast Growth Factor Family: THE COMPLETE MAMMALIAN FGF FAMILY J. Biol. Chem., June 9, 2006; 281(23): 15694 - 15700. [Abstract] [Full Text] [PDF]

				H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, K. P. Rosenblatt, M. G. Baum, S. Schiavi, M.-C. Hu, O. W. Moe, et al. Regulation of Fibroblast Growth Factor-23 Signaling by Klotho J. Biol. Chem., March 10, 2006; 281(10): 6120 - 6123. [Abstract] [Full Text] [PDF]

				S. L. Ferrari, E. Seeman, and G. J. Strewler Clinical and Basic Research Papers - October 2005 Selections IBMS BoneKEy, November 1, 2005; 2(11): 1 - 6. [Full Text] [PDF]